TrialThe Canadian journal of cardiology2008

A randomized, controlled trial of the effects of rosiglitazone on adipokines, and inflammatory and fibrinolytic markers in diabetic patients: study design and protocol.

Milan Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.